Comparison of Pharmacokinetic Parameters of Mycophenolic Acid in Two Groups of Iranian Kidney Transplant Patients
Authors:
- 23 March 2018
- journal article
- Published by Taylor & Francis in International Journal of Pharmacokinetics
- Vol. 3 (2) , 61-68
Abstract
Aim: Mycophenolate mofetil is widely used in organ transplantation to prevent acute rejection. Following oral administration, it is rapidly converted to mycophenolic acid (MPA). Effectiveness and the incidence of rejection is influenced by area under the concentration–time curve (AUC). Effect of time after transplantations on pharmacokinetic (PK) parameters is considered. Method: PK parameters of MPA was characterized in two different groups of Iranian kidney transplant patients. MPA plasma concentrations following oral administration of 1 g mycophenolate mofetil in a multiple dosage regimen were measured in 21 (group 1) and 31 (group 2) individuals. Group 1 for more than 3 months and group 2 had been transplanted for 9–10 days. Blood samples were taken before and at different time points following dose administration (0–12 h). Peak plasma concentration (Cmax), time to reach Cmax (Tmax), and AUC were calculated for each patient. Results: The first plasma peak was reached in the range of 0.6–2 and 0.3–2 h ...Keywords
This publication has 28 references indexed in Scilit:
- Changes in the Small Bowel of Symptomatic Kidney Transplant Recipients Converted from Mycophenolate Mofetil to Enteric-Coated Mycophenolate SodiumAmerican Journal of Nephrology, 2014
- Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients with Autoimmune DiseaseClinical Pharmacokinetics, 2013
- Pharmacokinetics of mycophenolic acid and its phenyl glucuronide metabolite in kidney transplant recipients with renal impairmentArchives of Medical Science, 2012
- Inosine Monophosphate Dehydrogenase (IMPDH) Activity as a Pharmacodynamic Biomarker of Mycophenolic Acid Effects in Pediatric Kidney Transplant RecipientsThe Journal of Clinical Pharmacology, 2011
- Therapeutic Drug Monitoring of Mycophenolic AcidClinical Journal of the American Society of Nephrology, 2007
- Therapeutic Monitoring of Mycophenolate MofetilClinical Journal of the American Society of Nephrology, 2007
- Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant RecipientsClinical Pharmacokinetics, 2007
- Pharmacokinetic Study of Mycophenolic Acid in Korean Kidney Transplant PatientsThe Journal of Clinical Pharmacology, 2004
- Population Pharmacokinetics and Bayesian Estimation of Mycophenolic Acid Concentrations in Stable Renal Transplant PatientsClinical Pharmacokinetics, 2004
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998